Search hospitals > California > Duarte
City of Hope Comprehensive Cancer Center - Duarte
Claim this profileDuarte, California 91010
Conducts research for Tumors
Conducts research for Acute Myeloid Leukemia
Conducts research for Colorectal Cancer
Conducts research for Pancreatic Cancer
Conducts research for Colorectal and Pancreatic Ductal Cancers
6 reported clinical trials
0 medical researchers
Summary
City of Hope Comprehensive Cancer Center - Duarte is a medical facility located in Duarte, California. This center is recognized for care of Tumors, Acute Myeloid Leukemia, Colorectal Cancer, Pancreatic Cancer, Colorectal and Pancreatic Ductal Cancers and other specialties. City of Hope Comprehensive Cancer Center - Duarte is involved with conducting 6 clinical trials across 19 conditions. There are 0 research doctors associated with this hospital, such as .Area of expertise
1Tumors
EGFR positive
Stage IV
Stage III
2Acute Myeloid Leukemia
Top PIs
Clinical Trials running at City of Hope Comprehensive Cancer Center - Duarte
Colorectal Cancer
Non-Hodgkin's Lymphoma
Acute Myeloid Leukemia
Pancreatic Cancer
Colorectal and Pancreatic Ductal Cancers
Tumors
Nasopharyngeal Carcinoma
Lymphoma
Nasopharyngeal Cancer
Kidney Cancer
BGB-3245 + Panitumumab
for Colorectal Cancer
The primary objectives of Part 1 of this study are to: * Assess the safety and tolerability of the combination of BGB-3245 and panitumumab in participants with advanced or metastatic colorectal cancer (CRC) with a known mutation status and tumor harboring an oncogenic mutation of v-Raf murine sarcoma viral oncogene homolog B; B-RAF proto-oncogene, serine/threonine kinase (BRAF), Kirsten rat sarcoma viral oncogene homolog (KRAS), or neuroblastoma RAS viral oncogene homolog (NRAS) with documented disease progression during or after at least 1 line of prior therapy. * Determine the maximum tolerated dose (MTD) of BGB-3245 in combination with panitumumab and the recommended phase 2 dose (RP2D) of the combination. The primary objective of Part 2 of this study is to determine the objective response rate (ORR) as assessed by initial investigator review using Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 with BGB-3245 and panitumumab combination treatment at the RP2D.
Recruiting1 award Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at City of Hope Comprehensive Cancer Center - Duarte?
City of Hope Comprehensive Cancer Center - Duarte is a medical facility located in Duarte, California. This center is recognized for care of Tumors, Acute Myeloid Leukemia, Colorectal Cancer, Pancreatic Cancer, Colorectal and Pancreatic Ductal Cancers and other specialties. City of Hope Comprehensive Cancer Center - Duarte is involved with conducting 6 clinical trials across 19 conditions. There are 0 research doctors associated with this hospital, such as .